XTRA:MED

Stock Analysis Report

Executive Summary

MEDICLIN Aktiengesellschaft operates hospitals and provides services in the areas of psychological sciences, neurosciences, and orthopedics in Germany.

Snowflake

Fundamentals

Fair value with moderate growth potential.

Share Price & News

How has MEDICLIN's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

MED

1.9%

DE Healthcare

1.4%

DE Market


1 Year Return

-6.8%

MED

-19.4%

DE Healthcare

3.7%

DE Market

Return vs Industry: MED exceeded the German Healthcare industry which returned -19.4% over the past year.

Return vs Market: MED underperformed the German Market which returned 3.7% over the past year.


Shareholder returns

MEDIndustryMarket
7 Day0%1.9%1.4%
30 Day0%-3.7%1.3%
90 Day4.8%-5.8%3.4%
1 Year-6.0%-6.8%-17.9%-19.4%7.0%3.7%
3 Year-4.4%-6.0%-28.1%-30.7%18.5%8.3%
5 Year46.3%43.8%15.8%9.4%42.2%22.9%

Price Volatility Vs. Market

How volatile is MEDICLIN's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MEDICLIN undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: MED (€5.45) is trading below our estimate of fair value (€14.06)

Significantly Undervalued: MED is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MED is poor value based on its PE Ratio (58.9x) compared to the Healthcare industry average (25.4x).

PE vs Market: MED is poor value based on its PE Ratio (58.9x) compared to the German market (19.3x).


Price to Earnings Growth Ratio

Low PEG Ratio: MED is poor value based on its PEG Ratio (1.3x)


Price to Book Ratio

PB vs Industry: MED is good value based on its PB Ratio (1.4x) compared to the DE Healthcare industry average (1.5x).


Next Steps

Future Growth

How is MEDICLIN forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

45.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MED's forecast earnings growth (45.8% per year) is above the savings rate (0.2%).

Earnings vs Market: MED's earnings (45.8% per year) are forecast to grow faster than the German market (12.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MED's revenue (4.7% per year) is forecast to grow slower than the German market (5% per year).

High Growth Revenue: MED's revenue (4.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if MED's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has MEDICLIN performed over the past 5 years?

-10.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: MED's earnings have declined by -10.8% per year over the past 5 years.

Accelerating Growth: MED's earnings growth over the past year (5.2%) exceeds its 5-year average (-10.8% per year).

Earnings vs Industry: MED earnings growth over the past year (5.2%) underperformed the Healthcare industry 19.5%.


Return on Equity

High ROE: MED's Return on Equity (2.4%) is considered low.


Return on Assets

ROA vs Industry: MED's Return on Assets is below or equal to the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: MED's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is MEDICLIN's financial position?


Financial Position Analysis

Short Term Liabilities: MED's short term assets (€150.4M) exceeds its short term liabilities (€140.5M)

Long Term Liabilities: MED's short term assets (150.4M) do not cover its long term liabilities (562.6M)


Debt to Equity History and Analysis

Debt Level: MED's debt to equity ratio (45.2%) is considered high

Reducing Debt: MED's debt to equity ratio has increased from 38% to 45.2% over the past 5 years.

Debt Coverage: MED's debt is well covered by operating cash flow (61.1%).

Interest Coverage: MED's interest payments on its debt are not well covered by EBIT (0.6x coverage).


Balance Sheet

Inventory Level: MED has a high level of physical assets or inventory.

Debt Coverage by Assets: MED's debt is covered by short term assets (assets are 1.829740x debt).


Next Steps

Dividend

What is MEDICLIN's current dividend yield, its reliability and sustainability?

0.92%

Current Dividend Yield


Dividend Yield vs Market

company0.9%marketbottom25%1.5%markettop25%3.8%industryaverage2.0%forecastin3Years0.9%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: MED's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.47%).

High Dividend: MED's dividend (0.92%) is low compared to the top 25% of dividend payers in the German market (3.83%).

Stable Dividend: MED's dividend payments have been volatile in the past 10 years.

Growing Dividend: MED's dividend payments have not increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (54.1%), MED's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: MED's dividends in 3 years are forecast to be thoroughly covered by earnings (13% payout ratio).


Next Steps

Management

What is the CEO of MEDICLIN's salary, the management and board of directors tenure and is there insider trading?

7.3yrs

Average board tenure


CEO

Volker Hippler (49yo)

3.5yrs

Tenure

0

Mr. Volker Hippler has been Chairman of Management Board at MEDICLIN Aktiengesellschaft since April 01, 2016. Mr. Hippler has been Member of Management Board at MEDICLIN Aktiengesellschaft since April 01,  ...


Board Age and Tenure

7.3yrs

Average Tenure

Experienced Board: MED's board of directors are considered experienced (7.3 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Carmen Schulz

    Head of Theraphy

    • Tenure: 0yrs
  • Volker Hippler (49yo)

    Chairman of Management Board

    • Tenure: 3.5yrs
  • Tino Fritz (41yo)

    CFO & Member of the Management Board

    • Tenure: 1.1yrs
  • Mario Waidele

    Head of Group Accounting

    • Tenure: 0yrs

Board Members

  • Brigitte Mohn

    Member of Advisory Board

    • Tenure: 0yrs
  • Hans Hilpert

    Deputy Chairman of Supervisory Board

    • Tenure: 17.4yrs
  • Günter Neubauer

    Member of Advisory Board

    • Tenure: 0yrs
  • Ulrich Wandschneider (58yo)

    Chairman of Supervisory Board

    • Tenure: 7.3yrs
    • Compensation: €23.25k
  • Michael Bock (56yo)

    Member of the Supervisory Board

    • Tenure: 14.4yrs
    • Compensation: €14.25k
  • Andreas Tecklenburg

    Member of Advisory Board

    • Tenure: 0yrs
  • Axel Ekkernkamp

    Member of Advisory Board

    • Tenure: 0yrs
  • Walburga Erichsmeier

    Employee Representative Member of Supervisory Board

    • Tenure: 7.1yrs
    • Compensation: €12.26k
  • Winfried Gleitze

    Member of Advisory Board

    • Tenure: 0yrs
  • Tom Giesler

    Employee Representative Member of Supervisory Board

    • Tenure: 7.1yrs
    • Compensation: €12.51k

Company Information

MEDICLIN Aktiengesellschaft's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MEDICLIN Aktiengesellschaft
  • Ticker: MED
  • Exchange: XTRA
  • Founded:
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: €258.875m
  • Shares outstanding: 47.50m
  • Website: https://www.mediclin.de

Number of Employees


Location

  • MEDICLIN Aktiengesellschaft
  • Okenstrasse 27
  • Offenburg
  • Baden-Württemberg
  • 77652
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MEDDB (Deutsche Boerse AG)YesBearer SharesDEEURDec 2000
MEDXTRA (XETRA Trading Platform)YesBearer SharesDEEURDec 2000
0NDGLSE (London Stock Exchange)YesBearer SharesGBEURDec 2000

Biography

MEDICLIN Aktiengesellschaft operates hospitals and provides services in the areas of psychological sciences, neurosciences, and orthopedics in Germany. It operates through Post-Acute, Acute, and Other Acti ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/19 21:10
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.